Please ensure Javascript is enabled for purposes of website accessibility

Argenta invests in expanded blister packaging capabilities in Dundee, Scotland, UK

Argenta invests in expanded blister packaging capabilities in Dundee, Scotland, UK

We are thrilled to announce the successful installation and qualification of our state-of-the-art blister packing equipment at our Dundee facility.

In January 2024, our Dundee facility, one of three Argenta manufacturing sites approved by both the EMA and FDA for good manufacturing practice (GMP), further expanded its capabilities with the addition of a high-tech blister line as part of its expanded labelling and packaging services. This latest investment is set to enhance our packaging operations, ensuring that we continue to meet the evolving needs of our customers and the market.

The successful inauguration of the new equipment is a testament to the excellent teamwork of our cross-functional project team. With their expertise, the first batch of product was seamlessly blister packed for stability and clinical studies in early February, marking a significant milestone in our journey towards operational excellence in animal health pharmaceutical manufacturing.

The new blister line not only boosts our current manufacturing efficiency but also opens the door to additional commercial opportunities. The increased capacity is perfectly timed to support the anticipated launch of an eagerly awaited product in 2025.

At Argenta, we are dedicated to providing our clients with the best quality services. The new blistering equipment is a shining example, emphasising a future where our production capabilities can keep pace with the demands of a dynamic animal health market.

For more information and enquiries about our contract manufacturing services and capabilities, please don’t hesitate to contact us.
 
About Argenta

Argenta is a global animal health services company, supporting companies big and small to develop and manufacture products that contribute to the health and wellbeing of pets and farm animals. Founded in 2006, we are the only combined global contract research, development, and manufacturing organisation (CRO/CDMO) dedicated to animal health and nutrition.

From ‘molecule to market’, our innovative solutions cover every stage of product development, spanning pharmaceutical sciences, novel drug delivery technologies, (pre-)clinical and regulatory services, and manufacturing. We’re trusted by the majority of the world’s top 10 animal health companies, and customers return to Argenta for our unparalleled, comprehensive support. With bases in Europe, New Zealand, and the USA, our 650+ colleagues are driven by our partnership approach and purpose: Healthy Animals. Let’s Make It Happen, Together.

Continue Reading